18
Participants
Start Date
June 30, 2006
Primary Completion Date
January 31, 2009
Study Completion Date
December 31, 2009
Ketamine
subject will then receive an intravenous bolus dose of ketamine 2 mg/kg as a rapid intravenous bolus, over less than two minutes just prior to CPB. In the non-CPB patients, ketamine will be administered just prior to the skin incision. All doses will be rounded to the nearest tenth of a milligram. Timed blood samples will be collected at standardized times after the completion of the ketamine infusion and samples will be obtained from an indwelling arterial line. Each blood sample for pharmacokinetic analysis will be 1 mL.
Arkansas Children's Hospital, Little Rock
Arkansas Children's Hospital Research Institute
OTHER